Hand-Foot Skin Reaction — on Lenvatinib: Prevention and Relief
Hand-foot skin reaction is one of the most common side effects of lenvatinib. It is not usually dangerous at first, but it can move from redness to painful blistering within days if the skin is not protected early.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Not dangerous at first — Mild redness and sensitivity are uncomfortable but manageable. Most people continue treatment with good skin care.
- Prevention beats treatment — Starting a thick moisturiser routine before symptoms appear is more effective than treating blisters after they form.
- Blistering changes the picture — Open skin or blisters that stop you walking need same-day contact with your team, not a wait-and-see approach.
- Your dose may need adjusting — Moderate to severe reactions often require a temporary dose pause. This is expected and does not mean the treatment has failed.
on Panel
Survival Rate*
Treated
(800+ reviews)
Hand-foot skin reaction on lenvatinib is uncomfortable but not usually dangerous. It becomes urgent when blistering, open sores, or pain that stops you walking appears. NCCN guidance on targeted therapy side effects recommends same-day contact at that point. Before it reaches that stage, a daily moisturising routine is the most effective way to stay ahead of it.
What can you do to prevent and manage the reaction at home?
- Start moisturising before symptoms appearUse a thick, urea-based cream or petroleum jelly on hands and feet from your first week on lenvatinib.
- Apply cream at least twice a dayMorning and night — more often if skin feels dry. Apply generously, not a thin layer.
- Wear cotton gloves or socks overnightApply cream, then cover with cotton so it absorbs while you sleep and reduces friction.
- Use warm water, not hotHot water strips the skin's protective oils. Use warm or cool water when bathing or washing hands.
- Choose padded, well-fitting shoesPressure from tight or hard-soled shoes worsens the reaction at the soles. Padded insoles reduce it.
- Tell your team about thickened skin earlyThickened patches can be treated before they crack. Do not cut or shave calluses yourself.
How serious is your reaction right now?
| Feature | Mild — manage at home | Moderate — call your team today | Severe — urgent review needed |
|---|---|---|---|
| Skin appearance | Redness, warmth, or sensitivity over pressure areas | Blisters, painful cracks, or peeling skin | Open sores, weeping skin, or signs of infection |
| Pain level | Minimal — does not change what you do | Uncomfortable — some daily tasks affected | Stops you walking or using your hands |
| Effect on daily life | None | Some activities harder than usual | Self-care significantly limited |
| Typically starts | Most often in the first few weeks of treatment — but can appear at any point | ||
| What to do | Continue skin care routine | Call your oncology team the same day | Contact your team urgently or go to hospital |
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
Is hand-foot skin reaction on lenvatinib dangerous?
At mild grades, it is not dangerous — but it needs to be taken seriously from the start, because it can worsen quickly if friction and dryness are not reduced.
The reaction happens because lenvatinib interferes with signals that maintain skin repair, making the palms and soles more sensitive to everyday pressure. The skin does not fail all at once — it thickens, then cracks, then sometimes blisters.
Where it becomes medically significant is when blisters break or the skin becomes infected. NCCN guidance on targeted therapy toxicities recommends holding or reducing the lenvatinib dose for moderate to severe reactions — so telling your team promptly protects your treatment, not just your skin.
What actually helps once the reaction has started?
Thick moisturisers — particularly urea-based creams or petroleum jelly — are the most consistently recommended home treatment. Apply them generously and often.
Reduce everything that creates friction or heat on the affected skin: hot water, tight footwear, tools with hard grips, walking barefoot on hard floors.
If there are thickened patches, your team may apply a keratolytic treatment to soften them before they crack. This is straightforward and worth asking about early rather than waiting for a crack to appear.
Did you know?
Hand-foot skin reaction from targeted therapies like lenvatinib tends to concentrate at pressure points — the soles of the feet and the fingertips — rather than spreading evenly across the whole palm.
This means the same patch of skin absorbs friction every time you walk or grip something. Cushioning and reducing pressure matter as much as the cream itself.
Source: NCCN Guidelines for Management of Targeted Therapy-Related Toxicities
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Will I definitely get hand-foot skin reaction on lenvatinib?
Not everyone does, but it is one of the more common side effects and it is worth starting preventive skin care whether or not you feel anything yet. Starting a thick moisturiser routine from the first week costs very little and is far easier than managing blistered skin once it has developed. If you are unsure which cream to use, ask your oncology nurse at your next appointment — they can recommend a formulation that is widely available in India.
Can I use any cream from the pharmacy, or does it need to be prescribed?
Many effective options are available without a prescription. Urea-based creams and petroleum jelly are both useful and widely available. What matters more than the brand is that the cream is thick rather than a light lotion, and that you apply it generously and consistently. Ask your team to confirm this is appropriate alongside anything else you are already using on your skin, particularly traditional oils or herbal preparations — some can increase sensitivity rather than reduce it.
Will this reaction mean my lenvatinib dose has to be reduced or stopped?
A mild reaction managed well at home usually does not require a dose change. A moderate to severe reaction — one that causes blistering, significant pain, or limits your daily activities — may need a temporary dose pause or reduction while the skin heals. NCCN guidance supports this approach, and for most people the dose can be restarted or adjusted rather than stopped permanently. Reporting the reaction early is what keeps the milder management options available to you.
My skin looks fine right now. Should I still start moisturising?
Yes. The most effective time to start is before any symptom appears, not after. The skin can change quickly once the reaction begins — sometimes within days. Starting a daily moisturising routine in your first week on lenvatinib, before anything is visible, is what the guidance recommends. Let your team know what product you are using, and ask them if there is anything they want you to avoid alongside it.
How long does the reaction last — will it get better over time?
The reaction does not always resolve completely while you remain on lenvatinib. For some people it stabilises with good skin care; for others it needs ongoing management throughout treatment. If the reaction settles to a mild level it becomes easier to live with. If it is moderate or severe and not improving, your team may adjust your dose — and the skin usually improves within a few weeks of a dose pause. Tell your team if it is not improving rather than assuming this is as good as it gets.